Pharmacy & Therapeutics Meeting 4Th Quarter P&T Committee Meeting 10000 Perkins Rowe Suite 500 Baton Rouge, LA 70810 Wayne Camp, RPh. Director of Pharmacy November 1, 2017

Agenda Formulary Changes Invega Sustenna Neomycin/polymixin/HC Susp FML Forte 0.25 Invega Trinza Modafinil tablets Pred Mild 0.12% Risperidal Consta Armodafinil tablets Oxycodone 5mg CAPSULE Abilify Maintena Cephalexin TABLETS Oxymorphone ER Orenitram Morphine ER Capsule (generic Kadian) Opsumet Suprax chew tablets Oxycontin Avonex Mavyret Zepatier Eliquis Ofloxacin tablets Alkeran Tradjenta Ciprofloxacin ER tablets Vigamox Jentadueto Ciprofloxacin 250mg/5mL Suspension Jentadueto XR Fondaparinux Lexiva Januvia Fragmin FOSAMPRENAVIR CALCIUM TAB 700 MG Janumet Sprycel tablets ZIAGEN SOLUTION & TABLETS Janumet XR Brimonidine 0.15% ophth soln ABACAVIR SOLUTION & TABLETS BD Pen Needles Brimonidine 0.2% ophth soln COPAXONE Non-Branded BD Pen Needles Betopic-S susp 0.25% GLATIRAMER Timolol ophth gel FLUTICASONE – SALMETEROL AER POWDER Moxifloxacin Betaxolol 0.5% ophth soln Ciloxan Ointment 0.3% Carteolol 1% ophth soln Tobrex Ointment 0.3% Levobunolol 0.5% ophth soln Tobradex Ointent 0.3 – 0.1% Timolol 0.25% and 0.5% ophth soln Combigan ophth soln Oxycodone concentrate solution (20mg/mL) Tobramycin/dexamethasone Suspension 0.3-0.1%

Agenda Annual PA Guideline Review Summary of Changes Ampyra Armodafinil and Modafinil Botox Cambi Celecoxib Colony Stimulating Factor Daraprim Erythropoiesis Stimulating Agents GnRH Analogs Growth Hormones Hepatitis C Injectable Anticoagulants Injectable Osteoporosis Interferons Lyrica Multiple Sclerosis Non-stimulant ADHD medications Nuedexta Oncology Agents Opioids (long-acting and short-acting) Ranexa Viscosupplements Weight loss agents Octreotide Synagis Otezla Cytokines/CAMs